The Side Effects of the Adjuvant Instillational Treatment with BCG for non-Muscle Invasive Bladder Cancer

Authors

  • I. Scarneciu Emergency Clinical County Hospital, Brasov, Romania
  • S. Lupu Emergency Clinical County Hospital, Brasov, Romania
  • R. Boja Emergency Clinical County Emergency, Tg. Mures, Romania
  • C.C. Scarneciu Emergency Clinical County Hospital, Brasov, Romania
  • V. Scarneciu Emergency Clinical County Hospital, Brasov, Romania

Keywords:

non-muscle invasive bladder cancer, side effects

Abstract

In addition to the benefits it confers intravesical immunotherapy with BCG, a negative aspect of this treatment is the side effects. They can be local or systemic, minor or major. This article is aimed at evaluating the frequency and severity of complications of adjuvant therapy with BCG for non-muscle invasive bladder cancer.

Author Biographies

I. Scarneciu, Emergency Clinical County Hospital, Brasov, Romania

Clinic of Urology

S. Lupu, Emergency Clinical County Hospital, Brasov, Romania

Clinic of Urology

R. Boja, Emergency Clinical County Emergency, Tg. Mures, Romania

Clinic of Urology;
University of Medicine and Pharmacy Tg. Mures, Romania

C.C. Scarneciu, Emergency Clinical County Hospital, Brasov, Romania

Clinic of Internal Medicine;
Transilvania University of Brasov, Romania
Faculty of Medicine

V. Scarneciu, Emergency Clinical County Hospital, Brasov, Romania

Clinic of Internal Medicine;  
Transilvania University of Brasov, Romania
Faculty of Medicine

Downloads

Published

2011-09-28

Issue

Vol. 4(53) No. 1 (2011)

Section

MEDICAL SCIENCES